July 2009--Albert Ko, MD, of the Division of Infectious Diseases, received a 3-year, $2.8 million phase II Small Business Innovative Research Grant (SBIR) from the NIH to Fully Develop a Rapid Diagnostic Test for Leptospirosis

Albert Ko, M.D., of the Division of Infectious Diseases, received a 3-year, $2.8 million phase II Small Business Innovative Research Grant (SBIR) from the NIH to fully develop a rapid diagnostic test for leptospirosis. Dr. Ko received this grant in collaboration with Chembio Diagnostic Systems, Inc., a U.S. company serving the increasing global demand for rapid tests needed for the prevention and treatment of infectious diseases and other conditions.

See full story.